Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Giant cell arteritis and polymyalgia rheumatica

G G Hunder1

  • 1Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.

The Medical Clinics of North America
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prominent perivascular enhancement in primary central nervous system vasculitis.

Clinical and experimental rheumatology·2008
Same author

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.

Rheumatology (Oxford, England)·2008
Same author

Primary CNS vasculitis with spinal cord involvement.

Neurology·2008
Same author

Cervical interspinous bursitis in active polymyalgia rheumatica.

Annals of the rheumatic diseases·2008
Same author

Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.

Clinical and experimental rheumatology·2004
Same author

Vasculitis. A collection of pearls and myths.

Rheumatic diseases clinics of North America·2001

Giant cell arteritis and polymyalgia rheumatica are linked inflammatory conditions. While both respond to corticosteroids, they require different dosages, and the prognosis is generally excellent.

Area of Science:

  • Rheumatology
  • Vasculitis
  • Immunology

Background:

  • Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are distinct yet related inflammatory conditions.
  • These conditions disproportionately affect individuals of Northern European descent.
  • Emerging research is elucidating the underlying pathogenesis of GCA and PMR.

Purpose of the Study:

  • To summarize the current understanding of giant cell arteritis and polymyalgia rheumatica.
  • To highlight the relationship between these two conditions.
  • To discuss treatment responses and patient outcomes.

Main Methods:

  • Review of recent investigations into the pathogenesis of GCA and PMR.
  • Analysis of treatment responses to corticosteroids.

Related Experiment Videos

  • Evaluation of vascular complications and overall prognosis.

    • Main Results:

    • GCA and PMR frequently coexist in patients.
    • Both conditions demonstrate responsiveness to corticosteroid therapy.
    • Differential corticosteroid dosing is necessary for optimal management of GCA and PMR.

    Conclusions:

    • Giant cell arteritis and polymyalgia rheumatica are closely associated rheumatologic disorders.
    • Effective management with corticosteroids leads to an excellent patient outlook.
    • Continued research into pathogenesis may offer further therapeutic insights.